EzzatiMObermeyerZTsoulakiI. Contributions of risk factors and medical care to cardiovascular mortality trends. Nat Rev Cardiol2015; 12: 508–530.
2.
RothGAForouzanfarMHMoranAE. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med2015; 372: 1333–1341.
3.
PerelPAvezumAHuffmanM. Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: The World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease. Glob Heart2015; 10: 99–110.
4.
KerrAJBroadJWellsS. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease?Heart2009; 95: 125–129.
CooneyMTReinerZSheuW. SURF – SUrvey of Risk Factor management: First report of an international audit. Eur J Prev Cardiol2012; 21: 813–822.
7.
Zhao M, Cooney MT, Klipstein-Grobusch K, et al. Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries. Eur J Prev Cardiol 2016; 23: 1202–1210.
8.
YusufSIslamSChowCK. Use of secondary prevention drugs for cardiovascular disease in the community in high income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. Lancet2011; 378: 1231–1243.
9.
KotsevaKWoodDDe BackerG. Cardiovascular prevention guidelines in daily practice: A comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet2009; 373: 929–940.
